Research Triangle Park

Farmers will soon have a new weapon in their crop protection arsenal. The U.S. Environmental Protection Agency (EPA) has approved…

The oncology startup Tavros Therapeutics has signed a five-year collaboration with Vividion Therapeutics that could bring as much as $430.5…

Curie Co, an early stage enzymes company based in New York City, has relocated to Research Triangle Park and hired…

A renovated life science campus in Research Triangle Park has been sold in a $288 million deal just a few…

North Carolina Biotechnology Center board member Karen LeVert is among three women receiving the 2022 Women in Agribusiness Demeter Award…

 NightHawk Biosciences has announced plans to build a new advanced biosafety level 2 laboratory that will add biodefense and infectious…

Triangle-based Fennec Pharmaceuticials has a lot riding on possible FDA approval of its new drug candidate – Pedmark. Up to $45 million,…

The North Carolina Biotechnology Center awarded 32 grants and loans totaling $3,304,543 to universities, bioscience companies and nonprofit organizations in…

Evoca – Belgium-based Biotalys’ new biofungicide – has done it again. The food and crop protection company’s first protein-based product that uses…